Intra-Cellular Therapies Inc. (ITCI) Social Stream



Intra-Cellular Therapies Inc. (ITCI): $58.92

-0.18 (-0.30%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ITCI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 389

in industry

Intra-Cellular Therapies Inc (ITCI) Price Targets From Analysts

Use the tables below to see what analysts covering Intra-Cellular Therapies Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 7 $70 $45 $53 $62.68 -15.44%
2021-12-06 7 $70 $45 $53.428 $62.68 -14.76%
2021-12-20 7 $85 $46 $56.666 $62.68 -9.59%
2021-12-21 7 $85 $46 $59.285 $62.68 -5.42%
2022-01-06 7 $85 $46 $59.428 $62.68 -5.19%
2022-01-23 7 $85 $46 $60 $62.68 -4.28%
2022-01-28 7 $85 $46 $60.142 $62.68 -4.05%
2022-03-02 7 $85 $49 $60.571 $62.68 -3.36%
2022-03-08 7 $90 $55 $65.142 $62.68 3.93%

The Trend in the Analyst Price Target


ITCI's average price target has moved up $13.01 over the prior 38 weeks.

Over the past 46 weeks, ITCI's average upside potential has been 37.24%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-04 5 81 40 50.440 34.60 45.78%
2021-09-11 5 81 40 50.440 33.24 51.74%
2021-12-06 7 70 45 53.428 35.20 51.78%
2021-12-21 6 85 46 59.285 48.20 23%
2022-03-02 7 90 49 64.285 57.05 12.68%

ITCI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.29 5 2 0 0 0 7

The Trend in the Broker Recommendations


Over the past 120 days, ITCI's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Intra-Cellular Therapies Inc's upside potential (average analyst target price relative to current price) is higher than 112.97% of them.
  • In terms of how Intra-Cellular Therapies Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -724.47% of that group.
  • In the context of Pharmaceutical Products stocks, Intra-Cellular Therapies Inc's average analyst price target is greater than 820.07% of them.
  • In the context of Pharmaceutical Products stocks, Intra-Cellular Therapies Inc's number of analysts covering the stock is higher than 649.69% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Intra-Cellular Therapies Inc are ISEE, IRWD, and INVA.

What is the outlook for ITCI? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6222 seconds.